tasocitinib (CP-690,550), a JAK (Janus kinase) inhibitor with immunosuppressive properties

potential indication under trial investigation: rheumatoid arthritis, psoriasis

www.oraltrials.com/ ORAL trial 網站，現在藥廠的行銷跑得好快啊！

www.ncbi.nlm.nih.gov/pub...

www.prnewswire.com/news-...